DeepLife Company
DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.
Investors
.png)
Connections from
Investors Number:
5.0
Total Funding:
6000000.0
Industry:
Early Drug Development
Founded Date:
2019-01-01
Headquarters:
Paris, Ile-de-France, France
Last Funding Date:
2022-09-02
Last Funding Type:
Series A
Funding Status:
Early Stage Venture